The Chemours Company has completed its spin-off from DuPont and has launched as an independent, publicly traded corporation. The company’s common stock is trading on the New York Stock Exchange under the symbol “CC.”

Chemours is a global chemical company with market positions in titanium technologies, fluoroproducts, and chemical solutions. The company offers a broad range of refrigerants for the air conditioning and refrigeration industries under the brand names Opteon^®, Freon^®, and ISCEON^®.

“We think of Chemours as a 200-hundred-year-old start-up,” said Mark Vergnano, president and chief executive officer of Chemours. “We bring to the market a rich heritage based on our DuPont legacy and built on industry leadership and innovation adding the energy and agility of a customer-centered, global business fresh out of the starting gate. Our businesses are already known for pioneering application development and world-class product stewardship and safety. Our workforce is among the best in the industry; they bring years of experience, deep chemistry expertise, and outstanding engineering knowledge to our more than 5,000 customers across the globe.

“Together, we’re going to build on our strengths, while becoming more streamlined and responsive,” Vergnano continued. “We are focusing our efforts on reducing our cost structure, enhancing our portfolio, and driving growth that supports customer demand. Three strategic cornerstones define Chemours today: optimizing our asset base, increasing cash flow, and allocating capital strategically.”

Chemours, headquartered in Wilmington, Delaware, has approximately 9,000 employees across 37 manufacturing sites serving more than 5,000 customers in North America, Latin America, Asia-Pacific, and Europe. For more information, visit www.chemours.com.